From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimes
Parameters Correlated | Study subgroups (chelation treatment) | ||
---|---|---|---|
Chelator | DFX n = 26 | DFO +/−DFP n = 10 | Total n = 36 |
uNAG vs. Total amount of total iron transfused for prior 10 years | r = 0.02, p = 0.89 | r = 0.7, p = 0.02 | r = 0.08, p = 0.6 |
uNAG vs. Mean serum ferritin for the prior 10 years | r = − 0.028, p = 0.88 | r = 0.62, p = 0.07 | r = − 0.35, p = 0.03 |
uNAG vs. Heart T2* MRI ms. | r = 0.54, p = 0.01 | r = 0.2517, p = 0.4 | r = 0.47, p < 0.01 |
Urinary Ca/Cr ratio vs Hb levels | r = 0.32, p = 0.1 | r = 0.7, p = 0.018 | r = 0.41, p = 0.001 |
Urinary Ca/Cr ratio vs. Mean serum ferritin for the prior 10 year | r = − 0.35, p = 0.03 | r = − 0.68, p = 0.03 | r = − 0.35, p = 0.03 |
Urinary Ca/Cr ratio vs. Amount of iron transfused over the prior10 years | r = −0.12, p = 0.5 | r = − 0.55, p = − 0.09 | r = − 0.4, p = − 0.014 |